10th February 2021

Job Seekers Flock To Salesforce’s Career Portal As The Company Announces Flexible WFH Policies Post-pandemic

Dear Reader,

Welcome to another edition of Under60 Daily - a brief rundown of the top happenings in the business world, compiled by hand to exclude the clutter and ensure you get up to speed in under a minute.

Programming note: We’re thinking of handing out rewards to people who share the gift of Under60 with their friends and family. Every referral counts, so start sharing by clicking the button below! Rewards will be announced soon.


[Earnings] Twitter’s Q4 2020 revenue stood at $1.3 billion, reflecting a YoY rise of 28% and beating analyst estimates. Despite the improved financial performance, the company’s average daily monetizable users touched 192 million, just short of the 194 million that analysts expected. Shares of Twitter rose by 3% after the earnings release. 

Over60: Business Insider

[Sovereign Debt] Spain has received more than €65 billion worth of orders for its new €5 billion 50-year bond issuance. Spain successfully sold the bonds with a coupon rate of 1.45%, compared to the 3.45% coupon it currently pays for similar bonds raised in 2016. Similarly, yields on Italian 10-year bonds fell below 0.5% as investor optimism grew around Mario Draghi’s new government. 

Over60: FT

[Labour] Salesforce became one of the first major tech companies to declare the 9-to-5 workday dead and instead will be giving employees the option of three different schedules. ‘Flex,’ the workstyle that will apply to most of Salesforce calls for 1-3 days in the office for team collaboration, customer meetings, and presentations.

Over60: The Verge, Salesforce

[Markets] SoftBankGroup Corp. plans to put $900 million into red-hot gene-sequencing company Pacific Biosciences of California Inc. As the Japanese technology conglomerate ramps up a new public-equity investing the effort.

Over60: WSJ, Reuters

[M&A] Bain Capital and Cinven agreed to acquire Lonza Group AG’s specialty ingredients unit, bringing to a close one of the most hotly contested sales in European chemicals. The deal is worth 4.2 billion Swiss francs ($4.7 billion) when including debt.

Over60: Bloomberg, Reuters


If this was forwarded to you, subscribe here.

We thrive on subscriber feedback. Feel free to reach out to us on Instagram

Follow us on Instagram!